MAR 28, 2020 8:39 AM PDT

The Antibody Test to See if You've Already Had the Coronavirus

WRITTEN BY: Annie Lennon

Knowing whether you’ve had the virus or not may not just reduce your need to panic- but also better help epidemiologists map out the spread of the virus. Now, Henry Schein Inc, the world’s largest distributor of dental and medical supplies, has released an antibody rapid blood test that can tell you if you’ve had the coronavirus before. And it does this in less than 15 minutes. 

Known as Standard Q COVID-19 IgM/IgG Rapid Test, it is a rapid immunochromatography test designed to detect specific IgM and IgG antibodies associated with the novel coronavirus from blood drawn by a pinprick. Detecting the presence of these antibodies, when taken with other information including the presence of symptoms and medical history, the test allows medical professionals to tell whether a person has already been infected by the virus, and whether they may be currently infected by it too. 

Currently available under emergency guidance by the US Food and Drug Administration, Stanley M Bergman, chairman of the Board and CEO of Henry Schein said, “This pandemic is an unprecedented situation, and making rapid diagnostic tools available to health care professionals is critical for detecting and mitigating the spread of the coronavirus.”

Other private companies have also begun selling blood tests capable of detecting coronavirus antibodies. For example, California-based Biomerica sells its tests for less than $10, and has already had orders placed from Europe and the Middle East. Chembio Diagnostics from New York has reportedly received an order for $4 million- worth of antibody tests against the virus, while South Korean test maker, Sugantech, is also reportedly producing tests. 

Meanwhile, researchers are also investigating the viability of antibody tests. Fatima Amanat, a PhD candidate at the Icahn School of Medicine at Mount Sinai, is currently developing tests for first responders and healthcare providers in particular. She said,  “Right now, if you have a highly infectious COVID-19 patient, it's really a problem to send a nurse who is not immune to it already because she’s so susceptible. Our test would be for all the doctors and healthcare providers, to see if they're already immune to it and have antibodies.”



Sources: US Dental Tribune, Vice and Reuters 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUL 24, 2020
Cancer
A New Biomarker Candidate for Cancer Diagnostics
JUL 24, 2020
A New Biomarker Candidate for Cancer Diagnostics
One of the best tools in the fight against cancer is diagnostics. In 2018, colorectal cancer was the second most lethal ...
JUL 21, 2020
Health & Medicine
FDA Produces Draft Guidelines on Developing Cannabis Drugs
JUL 21, 2020
FDA Produces Draft Guidelines on Developing Cannabis Drugs
The FDA’s Center for Drug Evaluation and Research has produced guidelines for research into cannabis-related ingre ...
JUL 31, 2020
Drug Discovery & Development
Researchers Reverse Advanced Alzheimer's in Mice
JUL 31, 2020
Researchers Reverse Advanced Alzheimer's in Mice
Researchers from Macquarie University have found a way to reverse the effects of memory loss in mice with advanced demen ...
AUG 11, 2020
Drug Discovery & Development
Engineering Drug-Producing Bacteria
AUG 11, 2020
Engineering Drug-Producing Bacteria
Researchers at Rice University worked to program a bacterium, Escherichia coli, to produce a synthetic "noncanonica ...
AUG 25, 2020
Cannabis Sciences
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
AUG 25, 2020
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
The US Food and Drug Administration has approved Epidiolex, a cannabidiol (CBD) oral solution, to treat seizures linked ...
SEP 01, 2020
Drug Discovery & Development
First Novel Compounds to Inhibit Cancer-Linked Enzymes
SEP 01, 2020
First Novel Compounds to Inhibit Cancer-Linked Enzymes
Researchers from the University of Michigan Rogel Cancer Center have worked on creating a therapeutic-based compound tha ...
Loading Comments...